David Harris becomes new ISN Presidenticlaron
ISN has announced the appointment of David Harris (Australia) as its new president. He succeeds Adeera Levin, from University of British Columbia (Canada), who held the post from 2015 until the ISN World Congress of Nephrology in April 2017.
Commenting on the focus of his presidency, he says: ‘During the next two years, ISN will have a renewed focus on end-stage kidney disease [ESKD], specifically improving global access to integrated ESKD care. ISN is already active in this area, but much more can be achieved by bringing together and building on these existing activities.’ Through advocacy, education and research, acute kidney injury (AKI) and chronic kidney disease (CKD) will remain center stage so our achievements to date can keep evolving.
David Harris is Professor of Medicine at The University of Sydney, Director of Nephrology and Dialysis in the Western Sydney Renal Service, and Director of the Renal Failure Laboratory in the Centre for Transplantation and Renal Research, Westmead Institute for Medical Research.
He was Past-President of the Asian Pacific Society of Nephrology, and Chairman of the Advisory Board of the Australasian Kidney Trials Network. He received the Distinguished Professorial Award from the University of Sydney in 2016) and the Priscilla Kincaid-Smith Medal for outstanding clinical and scientific achievement in research into treatment of diseases of kidney & urinary tract (2012).
He has published more than 280 papers, and given more than 200 invited national and international presentations. His major clinical and research interests include progressive CKD and dialysis, and his laboratory interests are focused on pathogenesis of and novel therapies for progressive CKD.